M-701 is under clinical development by Wuhan YZY Biopharma and currently in Phase III for Ovarian Cancer. According to GlobalData, Phase III drugs for Ovarian Cancer have a 36% phase transition ...

M-701 is under clinical development by Wuhan YZY Biopharma and currently in Phase II for Malignant Ascites. According to GlobalData, Phase II drugs for Malignant Ascites does not have sufficient ...

Concord Enviro Systems Ltd has set a price band of Rs 665-701 per share for its upcoming ... fresh issue worth Rs 175 crore and an offer for sale (OFS) of up to 4.64 million shares by existing ...

Xbox has launched its massive Countdown Sale for 2024 with major discounts on many of the year's biggest games for PC, Xbox One, and Xbox Series X|S. Select Xbox and third-party games are heavily ...

KTM is set to introduce the 390 Adventure S and 390 Enduro R in India in January 2025, marking the debut of the brand's 390 Adventure lineup. KTM 390 Adventure S and 390 Endure R will be launched ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the Multicloud The Future of the Internet ...

Setting a high standard in the adventure motorcycle segment, the Norden 901 allows touring enthusiasts to discover the hidden corners of the globe. Highly capable on road and excelling off road, the ...

(RTTNews) - Corbus Pharmaceuticals Holdings Inc. (CRBP), a biopharmaceutical company, today, announced that the FDA has granted Fast Track Designation to CRB-701 in treating relapsed or refractory ...

CRB-701 (SYS6002) is a next-generation antibody drug conjugate (ADC) targeting Nectin-4 that contains a site-specific, cleavable linker and a precise drug antibody ratio of 2 using MMAE as the ...

Welcome to MCN's guide to Husqvarna, your ultimate resource for everything related to Husqvarna motorcycles. Whether you're a seasoned rider or a newcomer to the world of motorcycling, our ...